• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Nov. 5 Suven Life Sciences Ltd is showcasing its research on some new chemical entities (NCEs) with applications in neuroscience at the annual meeting of the Society for Neuroscience (SFN) currently being held at San Diego, USA from November 3 to 7.

The Hyderabad-based company is presenting new data of its NCEs in the five areas of neuroscience viz. Alzheimer’s, schizophrenia, Parkinson, sleep and obesity diseases for which it had been granted nine product patents (two from EU, three from India, two from Australia and two from New Zealand).

One of the focus areas for Suven’s discovery research team is central nervous system (CNS) disorders through novel mechanisms using small-molecule medicinal chemistry approaches. Its discovery scientists here are currently pursuing innovative ways to develop treatments for a variety of CNS disorders like Alzheimer’s Schizophrenia, and cognitive disorders, sleep, neurodegeneration and obesity through CNS targets, according to a release.

More Stories on : Research & Development | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Suven Life showcases new chem entities

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line